Ovarian Function Suppression Plus Tamoxifen Significantly Reduces Premenopausal Breast Cancer Recurrence Over Tamoxifen and Further Reduction Is Seen When Combined with Exemestane By Ogkologos - July 6, 2026 89 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SOFT and TEXT studies Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Incidence, Relative Risk and Risk Factors for Chronic Comorbidities in Long-Term... July 22, 2020 Will Ponsegromab Be a Game Changer for Cancer Cachexia? October 17, 2024 New Research Discovers How Scalp Cooling Helps Chemo Patients Keep Their... February 6, 2021 Neoadjuvant Treatment with Dual Immune Checkpoint Inhibitors Plus Chemotherapy Produces Numerically... March 23, 2023 Load more HOT NEWS Registered Dietitian vs. Nutritionist EMA Recommends Extension of Therapeutic Indications for Olaparib to Patients with... John Cena Set The Record For Most Make-A-Wish Visits And He... ESMO Highlights Key Issues for Patients with Cancer and Their Carers...
